In this issue of Cell, Gabut and colleagues (2011) identify a new splice variant of FOXP1 that directly regulates the expression of pluripotency genes. It endows human embryonic stem cells with their pluripotent nature and is required for the reprogramming of somatic cells to induced pluripotent stem cells.
The past few years have seen remarkable progress in our understanding of the mechanistic basis of pluripotency, including the identification of key factors required for maintaining the pluripotent state of human embryonic stem cells (ESCs) (Chen et al., 2008; Kim et al., 2008; Silva et al., 2009) . Moreover, one of the great breakthroughs of this decade was the discovery that a only few critical transcriptions factors, such as the combination of Oct4, Sox2, Klf4, and c-Myc, are sufficient to reprogram somatic cells into induced pluripotent stem (iPS) cells (Takahashi et al., 2007) . These factors appear to activate a transcriptional network that endows cells with pluripotency (Samavarchi-Tehrani et al., 2010) , but gene expression can be regulated by numerous processes other than transcription, including chromatin modifications, RNA stability, and pre-RNA splicing. How these processes contribute to pluripotency has been largely understudied in human ESCs. Now in this issue of Cell, Gabut et al. (2011) break this field wide open by identifying an alternative splicing ''switch'' at the top of the pluripotency transcriptional network.
Alternative splicing-the process by which exons can be joined together in different patterns such that a single gene can give rise to multiple transcripts-is known to regulate key developmental decisions in a number of systems (Nilsen and Graveley, 2010) . Perhaps the best known example is the sex-determination pathway in Drosophila (Salz, 2011) . This pathway consists of five genes encoding premRNAs that are spliced in a sex-specific manner ( Figure 1A ). The genes are organized in a hierarchy in which the splicing of an upstream gene regulates that of downstream genes. The genes at the bottom of this hierarchy, dsx (doublesex) and fru (fruitless), encode transcription factors, and the male-specific and female-specific protein variants of each factor regulate distinct sets of target genes. Thus, these regulated splicing events act in a switch-like manner to specify nearly all aspects of sex determination and courtship behavior.
To explore the role of alternative splicing in human ESC pluripotency, Gabut et al. use microarrays that can detect different splicing variants. These experiments reveal numerous splicing events that change as human ESCs differentiate into neural precursor cells, including one in the FOXP1 gene. This event involves a previously unannotated exon that is included in human ESCs but skipped in differentiated cells ( Figure 1B) . Strikingly, the exon's sequence and its stem cell specificity is conserved in mouse, suggesting that it might play a significant role in stem cell biology.
FOXP1 encodes a member of the forkhead family of transcription factors, which recognize particular DNA sequences through a ''forkhead domain.'' FOXP1 is an essential gene that is broadly expressed and required for the establishment of specific cell types. Fusions of FOXP1 with other genes or loss of FOXP1 function are associated with many different types of cancer (Wang et al., 2004; Dasen et al., 2008) . Intriguingly, the ES-specific exon is located within the forkhead domain, suggesting that the FOXP1 splice variants may encode proteins with distinct DNA-binding specificities. To examine this possibility, Gabut and colleagues determine the DNA-binding specificity of both the traditional FOXP1 and the ES-specific FOXP1 (FOXP1-ES) with microarrays that contain oligonucleotides with all possible 8-mers. Whereas FOXP1 preferentially recognizes the sequence GTAAACA, FOXP1-ES preferentially binds to AATAAACA and CGATACAA. These results suggest that alternative splicing of FOXP1 could regulate the activation of distinct transcriptional programs.
Next Gabut and colleagues use two complementary approaches to determine whether FOXP1 and FOXP1-ES control different sets of genes. First, they deplete either FOXP1 or FOXP1-ES by RNA interference (RNAi) and then sequence the resulting transcriptome. This allows them to identify genes that increase or decrease expression upon disruption of a specific FOXP1 isoform. Additionally, the authors use chromatin immunoprecipitation experiments to identify where FOXP1 and FOXP1-ES bind in the genome. The results of these experiments are striking. FOXP1-ES, but not FOXP1, enhances expression of many pluripotency genes, including OCT4, NR5A2, and NANOG, by directly binding to their promoters. Simultaneously, FOXP1-ES represses the expression of genes that control differentiation.
These intriguing observations prompt the authors to investigate the role and requirement for FOXP1-ES in stem cell pluripotency and reprogramming. Increasing the expression of FOXP1-ES, but not FOXP1, prevents differentiation of mouse ESCs under conditions that promote efficient differentiation. Conversely, depleting FOXP1-ES, but not FOXP1, inhibits reprogramming of mouse embyronic fibroblasts via the activation of Oct4, Klf4, c-Myc, and Sox2.
The article by Gabut and colleagues is a landmark study that shifts the paradigm for mechanisms regulating embryonic stem cell pluripotency and reprogramming in mammals. Instead of a transcriptional network being at the top of the hierarchy, an alternative splicing switch can now be placed upstream of this network, as FOXP1-ES activates expression of pluripotency genes and represses expression of differentiation genes. Despite changing our understanding of the regulatory network controlling pluripotency and reprogramming, this work also raises many questions to be addressed in future studies. For instance, what controls the FOXP1-FOXP1-ES splicing switch? What splicing factors are responsible for flipping this switch, and how are their expression and activities regulated? Answering these questions is like hunting down the ''chicken-or-the egg'' paradox, but they will ultimately uncover the master regulator of stem cell pluripotency. 
tra (transfer), msl-2 (male-specific lethal-2), dsx (doublesex), and fru (fruitless)
genes are all differentially spliced in males and females. Sxl encodes a female-specific RNA-binding protein that autoregulates itself and represses the male-specific isoforms of tra and msl-2. The female-specific isoform of tra encodes a female-specific RNA-binding protein that activates expression of the female-specific isoforms of both dsx and fru. These isoforms encode female-specific transcription factors that activate expression of genes specifying female physical traits and sexual behavior. (B) An alternative splicing regulatory switch in FOXP1 regulates pluripotency and reprogramming (Gabut et al., 2011) . FOXP1 contains two exons, 18 and 18b, which are spliced in a mutually exclusive manner. In embryonic stem cells (ESCs), exon 18b is included. This results in the production of FOXP1-ES, which binds to and activates pluripotency genes while simultaneously repressing differentiation genes. In differentiated cells, only exon 18 is included, resulting in the production of FOXP1, which activates the expression of differentiation genes.
Although genes associated with human autism spectrum disorders have been identified, bridging the gap between genetics and the patchwork of behavioral deficits associated with the disease remains an enormous challenge. Peñ agarikano et al. (2011) now show that mice lacking CNTNAP2, a gene that causes a rare form of epilepsy associated with autistic features and language impairment, display similar phenotypes to their human counterparts, raising hopes that such models may speed the identification of neuronal circuitries underlying the core features of autism.
Disorders that affect behavior, including both psychiatric conditions and developmental disabilities, provide challenging opportunities and pitfalls for neuroscientists. In autism, a three-domain model describing deficits in communication, social interaction, and fixated or repetitive behaviors and interests has proven useful as a ''grammar'' to represent the nature of the deficits and to yield reliable diagnoses ( Figure 1A) . This model does not, however, necessarily reflect functional relationships between behaviors (Gotham et al., 2007) . Such limitations underlie both the strengths and weaknesses of bold, integrative approaches such as those found in this issue in Peñ agarikano et al. (2011) , which reports a comprehensive and ambitious series of experimental behavioral, neuropathological, and neurophysiological studies of CNTNAP2 knockout mice.
CNTNAP2, a gene on chromosome 7q35, is of particular interest because it has been shown to cause a rare form of epilepsy (Strauss et al., 2006) . These patients have severe intellectual disabilities and, like most individuals with severe cognitive deficits, are described as having features of autism. Although it likely accounts for fewer than 1% of cases of autism spectrum disorder (ASD) (Sanders et al., 2011) , CNTNAP2 has also been associated with specific language impairment (SLI), which is characterized by difficulties with grammatical aspects of language acquisition in the absence of related causes such as hearing loss (Bishop, 2010) . CNTNAP2 is also a downstream target of FOXP2, one of the first genes to have been identified as a cause of SLI.
In common with some human CNTNAP2 patients, CNTNAP2 mutant mice have epileptic seizures and display impaired migration of cortical projection neurons, cortical neuronal synchrony, and numbers of GABAergic interneurons. To quantify the behavioral impact of these anatomical and electrophysiological defects, the authors assess knockout and wild-type mice for behaviors considered analogous to the three domains of autism. Standards for interpreting behavioral data in mouse models have become more sophisticated (Silverman et al., 2010) . However, leaps made from findings to interpretations are still often substantial (Minshew and McFadden, 2011). Peñ agarikano et al. (2011) report multiple measures and address several confounding factors such as potential olfactory impairment and the effect of sedation. Most striking, though not obviously anticipated, is that the mutant mice have deficits across diverse contexts and domains. On average, mice lacking CNTNAP2 make fewer social approaches and engage in less vocalization and nesting. In contrast, perseveration, grooming, and digging (used to indicate repetitive behaviors) are enhanced, as are overall levels of activity.
Treatment with risperidone, an atypical antipsychotic drug licensed for the treatment of autism, increases nesting and decreases grooming, perseveration, and hyperactivity. However, risperidone has no effect on social approach or vocalization. The authors propose that these specific responses to pharmacological intervention are likely a result of the behaviors being driven by distinct neural circuits. Though the idea that social deficits and repetitive behaviors in autism are separable on an anatomical level is appealing, the absence of any attempt to address functional relationships between these deficits within individuals in
